Phase II Data Showing Clinical Benefits of Novel Once-Daily Oral ...
PR Newswire (press release) - New York,NY,USA
* One-year data show significant reductions in inflammatory disease activity and clinical relapse activity with daily oral FTY720 were maintained for up to one ...

---

fingolimod

Promising New MS Drug
6abc.com - Philadelphia,PA,USA
... and not injected. The experimental drug called Fingolimod was taken by study volunteers every day for six months. The results were ...

Oral MS Drug May Be Effective In Treating Multiple Sclerosis
All Headline News - USA
(AHN) - A new study suggests the experimental drug fingolimod may be effective in helping patients with relapsing multiple sclerosis. ...

New MS drug reportedly shows promise
ABC7Chicago.com - IL, USA
A new study suggests this first oral medication for MS may be on the horizon. The experimental drug is called Fingolimod. Scientists ...

---

tysabri

Blogging Stocks Interview: Ken Kam's best stock ideas
Blogging Stocks - USA
... Elan Corporation ADS (NYSE: ELN) This Irish biotech firm got slammed when its multiple sclerosis drug Tysabri was withdrawn from the market in 2005 after ...

---